152 related articles for article (PubMed ID: 11450593)
41. Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis.
Phung N; Pera N; Farrell G; Leclercq I; Hou JY; George J
Int J Mol Med; 2009 Aug; 24(2):171-80. PubMed ID: 19578790
[TBL] [Abstract][Full Text] [Related]
42. Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes.
Iredale JP; Goddard S; Murphy G; Benyon RC; Arthur MJ
Clin Sci (Lond); 1995 Jul; 89(1):75-81. PubMed ID: 7671571
[TBL] [Abstract][Full Text] [Related]
43. Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts.
Pereira RC; Jorgetti V; Canalis E
Am J Physiol; 1999 Sep; 277(3):E496-504. PubMed ID: 10484362
[TBL] [Abstract][Full Text] [Related]
44. [Effects of Shaoqiduogan on MMP-13, TIMP-1 expression in liver and hepatic stellate cells of hepatic fibrosis rats].
Sun W; Gui S; Wu L; Wang H; Wei W
Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1447-51. PubMed ID: 20822018
[TBL] [Abstract][Full Text] [Related]
45. Dynamics of collagen, MMP and TIMP gene expression during the granulomatous, fibrotic process induced by Schistosoma mansoni eggs.
Singh KP; Gerard HC; Hudson AP; Boros DL
Ann Trop Med Parasitol; 2004 Sep; 98(6):581-93. PubMed ID: 15324465
[TBL] [Abstract][Full Text] [Related]
46. Effects of a plasmid expressing antisense tissue inhibitor of metalloproteinase-1 on liver fibrosis in rats.
Jiang W; Wang JY; Yang CQ; Liu WB; Wang YQ; He BM
Chin Med J (Engl); 2005 Feb; 118(3):192-7. PubMed ID: 15740646
[TBL] [Abstract][Full Text] [Related]
47. Electroporative alpha-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation.
Wang CH; Lee TH; Lu CN; Chou WY; Hung KS; Concejero AM; Jawan B
Gene Ther; 2006 Jul; 13(13):1000-9. PubMed ID: 16511523
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.
Salmela MT; MacDonald TT; Black D; Irvine B; Zhuma T; Saarialho-Kere U; Pender SL
Gut; 2002 Oct; 51(4):540-7. PubMed ID: 12235077
[TBL] [Abstract][Full Text] [Related]
49. Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease.
Munsterman ID; Kendall TJ; Khelil N; Popa M; Lomme R; Drenth JPH; Tjwa ETTL
Histopathology; 2018 Oct; 73(4):612-621. PubMed ID: 29856896
[TBL] [Abstract][Full Text] [Related]
50. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
[TBL] [Abstract][Full Text] [Related]
51. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis.
Dudás J; Kovalszky I; Gallai M; Nagy JO; Schaff Z; Knittel T; Mehde M; Neubauer K; Szalay F; Ramadori G
Am J Clin Pathol; 2001 May; 115(5):725-35. PubMed ID: 11345837
[TBL] [Abstract][Full Text] [Related]
52. Regulatory role of extracellular matrix components in expression of matrix metalloproteinases in cultured hepatic stellate cells.
Li YL; Sato M; Kojima N; Miura M; Senoo H
Cell Struct Funct; 1999 Oct; 24(5):255-61. PubMed ID: 15216880
[TBL] [Abstract][Full Text] [Related]
53. Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes.
Théret N; Musso O; L'Helgoualc'h A; Clément B
Am J Pathol; 1997 Jan; 150(1):51-8. PubMed ID: 9006321
[TBL] [Abstract][Full Text] [Related]
54. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
Li YY; McTiernan CF; Feldman AM
Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
[TBL] [Abstract][Full Text] [Related]
55. Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis.
Otte C; Otte JM; Strodthoff D; Bornstein SR; Fölsch UR; Mönig H; Kloehn S
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):10-7. PubMed ID: 14758566
[TBL] [Abstract][Full Text] [Related]
56. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease.
Pereira TN; Lewindon PJ; Greer RM; Hoskins AC; Williamson RM; Shepherd RW; Ramm GA
J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):328-35. PubMed ID: 22157922
[TBL] [Abstract][Full Text] [Related]
57. Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice.
Pagenstecher A; Stalder AK; Kincaid CL; Volk B; Campbell IL
Am J Pathol; 2000 Jul; 157(1):197-210. PubMed ID: 10880390
[TBL] [Abstract][Full Text] [Related]
58. Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery.
Tasci I; Mas MR; Vural SA; Comert B; Alcigir G; Serdar M; Mas N; Isik AT; Ates Y
Liver Int; 2006 Mar; 26(2):261-8. PubMed ID: 16448466
[TBL] [Abstract][Full Text] [Related]
59. Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression.
Atta H; El-Rehany M; Hammam O; Abdel-Ghany H; Ramzy M; Roderfeld M; Roeb E; Al-Hendy A; Raheim SA; Allam H; Marey H
PLoS One; 2014; 9(11):e112384. PubMed ID: 25380300
[TBL] [Abstract][Full Text] [Related]
60. [Hepatic fibrogenesis].
Lee KS
Korean J Gastroenterol; 2006 Nov; 48(5):297-305. PubMed ID: 17132917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
